E2F3 amplification primes bladder cancer cells for premature mitosis
Preprint
Abstract
The E2F–RB pathway controls the G1/S checkpoint, and tumors often bypass it through RB1 or CDKN2A loss. Unlike these lesions, E2F3 amplification drives persistent excessive E2F-dependent transcription through S and G2 phases. This oncogene is frequently amplified in for example bladder cancer, but its impact on the cancer cell cycle remains unclear. Using isogenic bladder cancer models and patient data, we show that E2F3 amplification hyperactivates a mitotic gene expression program, including cyclin B1. This predisposes cells to unscheduled mitosis when the G2/M checkpoint is inhibited using the PKMYT1 inhibitor lunresertib, alone or in combination with low dosages of the WEE1 inhibitor zederosertib. E2F3 -amplified cells acquired resistance to lunresertib by permanently reducing cyclin B1 expression, thereby preventing premature mitotic entry. Importantly, this resistance was reversed by co-treatment with a low dose of WEE1 inhibitor. These findings identify PKMYT1-dependent CDK1 inhibition as a critical safeguard against premature mitosis in E2F3 -amplified bladder cancer. Thus, we uncover an opportunity for precision medicine strategies aimed at G2/M checkpoint inhibition to promote catastrophic mitosis in bladder cancer patients with E2F3 amplification and excessive cyclin B1 expression.Keywords
Funding Information
- NWO (OCENW.XS21.3.066)
- KWF Kankerbestrijding (11941/2018-2)
- KWF Kankerbestrijding (15812/2024-1)
- China Scholarship Council (201706140153)
This publication has 45 references indexed in Scilit:
- Cyclin E-induced replicative stress drives p53-dependent whole-genome duplicationCell, 2023
- SynergyFinder Plus: Toward Better Interpretation and Annotation of Drug Combination Screening DatasetsGenomics, Proteomics & Bioinformatics, 2022
- Gene Set Knowledge Discovery with EnrichrCurrent Protocols, 2021
- Excessive E2F Transcription in Single Cancer Cells Precludes Transient Cell-Cycle Exit after DNA DamageCell Reports, 2020
- WAPL-Dependent Repair of Damaged DNA Replication Forks Underlies Oncogene-Induced Loss of Sister Chromatid CohesionDevelopmental Cell, 2020
- Comprehensive Molecular Characterization of Muscle-Invasive Bladder CancerCell, 2017
- Searching for Drug Synergy in Complex Dose–Response Landscapes Using an Interaction Potency ModelComputational and Structural Biotechnology Journal, 2015
- Curtailing Overexpression of E2F3 in Breast Cancer Using siRNA (E2F3)-Based Gene SilencingArchives of Medical Research, 2012
- Nucleotide Deficiency Promotes Genomic Instability in Early Stages of Cancer DevelopmentCell, 2011
- Nuclear overexpression of the E2F3 transcription factor in human lung cancerLung Cancer, 2006